Active Ingredient: Gadofosveset
Gadofosveset is indicated for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.
For this indication, competent medicine agencies globally authorize below treatments:
0.12 - 0.12 mL per kg of body weight
From 0.12 To 0.12 mL per kg of body weight once every day
Adults: 0.12 ml/kg body weight (equivalent to 0.03 mmol/kg)
Dynamic imaging begins immediately upon injection. Steady state imaging can begin after the dynamic scan has been completed. In clinical trials, imaging was completed up to approximately one hour following injection.
It should be administered as a single intravenous bolus injection, manually, or by magnetic resonance injector (MR injector) over a period of time up to 30 seconds followed by a 25-30 ml normal saline flush.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.